Shanafelt T, Kuriakose C. Widespread clinician shortages create a crisis that will take years to resolve. NEJM Catal. 2023 Mar;4(3):CAT.23.0044. 10.1056/CAT.23.0044
Scholer M. Scheidegger: wenn wir so weitermachen, fahren wir das System an die Wand. Schweiz Arzteztg. 2017;98(15-16):495–7.
Wille N, Gilli Y. Qualität stärken statt Quantität steuern – Teil 1. Schweiz Arzteztg. 2022;103(37):26–8.
Wille N, Gilli Y. Wie gelingt Kostendämpfung ohne Versorgungseinbussen? – Teil 1. Schweiz Arzteztg. 2022;103(36):30–2.
Marty F. Hört auf, das Gesundheitswesen zu steuern. Schweiz Arzteztg. 2023;103(05):16–9.
Meyer PC, Brauchbar M: Trends und Herausforderungen im Gesundheitswesen Schweiz. Ärzteztg 2018; 99(33):1072-5
Porter ME, Pabo EA, Lee TH. Redesigning primary care: a strategic vision to improve value by organizing around patients’ needs. Health Aff (Millwood). 2013 Mar;32(3):516–25. 10.1377/hlthaff.2012.0961
Fuchs B, Bode B, Studer G, Breitenstein S. Wie entwickelt sich die Sarkomchirurgie? Leading Opinions Orthopädie&Rheumatologie. 2021;1:16–8.
Fuchs B, Studer G, Bode B, Wellauer H, Frei A, Theus C, et al.; SwissSarcomaNetwork. Development of a value-based healthcare delivery model for sarcoma patients. Swiss Med Wkly. 2021 Dec;151(5152):w30047. 10.4414/SMW.2021.w30047
Theus-Steinmann C, Schelling G, Heesen P, Breitenstein S, Scaglioni MF, Fuchs B. How is the spectrum of sarcoma surgery assessed? Cancers (Basel). 2023 Feb;15(4):1305. 10.3390/cancers15041305
Frei A, Scaglioni MF, Giovanoli P, Breitenstein S, Heesen P, Fuchs B; On Behalf Of The Swiss Sarcoma Network. Definition of the surgical case complexity in the treatment of soft tissue tumors of the extremities and trunk. Cancers (Basel). 2022 Mar;14(6):1559. 10.3390/cancers14061559
Heesen P, Studer G, Bode B, Windegger H, Staeheli B, Aliu P, et al. Quality of sarcoma care: longitudinal real-time assessment and evidence analytics of quality indicators. Cancers (Basel). 2022 Dec;15(1):47. 10.3390/cancers15010047
Mosku N, Heesen P, Christen S, Scaglioni MF, Bode B, Studer G, et al.; Swiss Sarcoma Network. The sarcoma-specific instrument to longitudinally assess health-related outcomes of the routine care cycle. Diagnostics (Basel). 2023 Mar;13(6):1206. 10.3390/diagnostics13061206
Mosku N, Heesen P, Studer G, Bode B, Spataro V, Klass ND, et al. Biopsy ratio of suspected to confirmed sarcoma diagnosis. Cancers (Basel). 2022 Mar;14(7):1632. 10.3390/cancers14071632
Wellauer H, Studer G, Bode-Lesniewska B, Fuchs B. Time and accuracy to establish the diagnosis of soft tissue tumors: a comparative analysis from the Swiss Sarcoma Network. Sarcoma. 2022 Apr;2022:7949549. 10.1155/2022/7949549